Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. Aarhus University Hospital, Aarhus, Denmark

Survival: 10.3 months
Toxicity Grade: 5
Treatments: Chemotherapy
Drugs: Pemetrexed
Country: Denmark
City/State/Province: Aarhus
Hospital: Aarhus University Hospital
Journal: Link
Date: 10/2006

This phase II study involved 64 patients with transitional cell carcinoma of the urothelium. The median patient age was 65 years and 83% were male.

Patients were treated with the chemotherapy agents pemetrexed and gemcitabine.

There was one treatment-related death due to infection. Grade 4 neutropenia, anemia, and shortness of breath were also reported.

The median overall survival was 10.3 months.

This study was supported by Eli Lilly, makers of gemcitabine and pemetrexed.

Correspondence: Dr. H. von der Maase; email:

E-mail to a Friend Email Physician More Information